1. Home
  2. SKYT vs NYXH Comparison

SKYT vs NYXH Comparison

Compare SKYT & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SKYT
  • NYXH
  • Stock Information
  • Founded
  • SKYT 1991
  • NYXH 2009
  • Country
  • SKYT United States
  • NYXH Belgium
  • Employees
  • SKYT N/A
  • NYXH N/A
  • Industry
  • SKYT Semiconductors
  • NYXH Medical/Dental Instruments
  • Sector
  • SKYT Technology
  • NYXH Health Care
  • Exchange
  • SKYT Nasdaq
  • NYXH Nasdaq
  • Market Cap
  • SKYT 445.1M
  • NYXH 394.1M
  • IPO Year
  • SKYT 2021
  • NYXH 2021
  • Fundamental
  • Price
  • SKYT $6.90
  • NYXH $6.06
  • Analyst Decision
  • SKYT Strong Buy
  • NYXH Strong Buy
  • Analyst Count
  • SKYT 3
  • NYXH 4
  • Target Price
  • SKYT $12.00
  • NYXH $14.50
  • AVG Volume (30 Days)
  • SKYT 528.3K
  • NYXH 290.0K
  • Earning Date
  • SKYT 05-07-2025
  • NYXH 05-13-2025
  • Dividend Yield
  • SKYT N/A
  • NYXH N/A
  • EPS Growth
  • SKYT N/A
  • NYXH N/A
  • EPS
  • SKYT N/A
  • NYXH N/A
  • Revenue
  • SKYT $342,269,000.00
  • NYXH $4,680,609.00
  • Revenue This Year
  • SKYT N/A
  • NYXH $504.18
  • Revenue Next Year
  • SKYT $22.65
  • NYXH $149.52
  • P/E Ratio
  • SKYT N/A
  • NYXH N/A
  • Revenue Growth
  • SKYT 19.39
  • NYXH 3.98
  • 52 Week Low
  • SKYT $5.63
  • NYXH $5.55
  • 52 Week High
  • SKYT $19.00
  • NYXH $12.21
  • Technical
  • Relative Strength Index (RSI)
  • SKYT 47.30
  • NYXH 31.41
  • Support Level
  • SKYT $6.34
  • NYXH $5.62
  • Resistance Level
  • SKYT $6.88
  • NYXH $6.09
  • Average True Range (ATR)
  • SKYT 0.53
  • NYXH 0.54
  • MACD
  • SKYT 0.10
  • NYXH 0.05
  • Stochastic Oscillator
  • SKYT 84.08
  • NYXH 27.76

About SKYT SkyWater Technology Inc.

SkyWater Technology Inc is a U.S.-based, independent, pure-play technology foundry that offers semiconductor development and manufacturing services from its fabrication facilities. In its technology as a service model, it leverages a foundation of proprietary technology, engineering to co-develop process technology intellectual property (IP) with its customers that enable disruptive concepts through its Technology Services for diverse microelectronics (integrated circuits) and related micro- and nanotechnology applications. It focuses on serving diversified, high-growth, end users in numerous vertical markets, including computation, aerospace and defense (A&D), automotive and transportation, bio-health, and industrial.

About NYXH Nyxoah SA

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Share on Social Networks: